Planning green light given for Bristol research centre

Pharmaceuticals company, Vectura has been given planning permission for a new 10,000m² facility on the Bristol & Bath Science Park in south-west England.

The state-of-the-art £58M building, which is anticipated to complete in 2025, will enable the company to expand its operations, providing new career opportunities for research and development in pharmaceutical and device development, as well as manufacturing and laboratory services. The facility has a goal to achieve a BREEAM ‘Excellent’ rating.

Vectura Chief Executive Officer Michael Austwick, said: “We are delighted that our plans to build a world-leading science facility have been approved by South Gloucestershire Council.

“The new-build will enable our already successful pharmaceutical company to continue and expand upon its vital work, providing innovative inhalation and other advanced drug delivery solutions that have the potential to improve the lives of patients around the world.”

Councillor Ben Burton, Cabinet Member responsible for Corporate Resources at South Gloucestershire Council, said: “The Bristol & Bath Science Park in South Gloucestershire offers a prime location for a company of this type as it is a world-class centre for science and technology businesses with a focus on research and development, innovation and collaboration.

“This new research and development facility will bring additional high-tech employment opportunities to our area and I’m pleased to see that Vectura’s plans for the new building include a number of environmental and sustainability considerations.”